Peripheral T cell tolerance is considered to be an important immunological response that inhibitsinappropriateimmune responses to both self and non-self antigens (Ags). However, tolerance is breached in disease that can manifest as allergic or autoimmune disease. Using a murine model of tolerance, induced by inhaled Ag, we have recently made interesting discoveries. In tolerized mice, we have identified cells expressing membrane-bound TGF-p and the T regulatory cell-specific transcription factor FOXP3. This novel cell type,TGF-pm+/FOXP3+, was not detectable in Ag-induced airway inflammation. Our studies have also allowed us to make an important distinction between soluble and membrane-bound TGF-J5. While soluble TGF- p potently inhibitednaive CD4+ T cell activation through inhibiting Ca2+ influx, Itk and NFAT activation, it was unable to inhibitAg-experienced cells. The novel TGF-pm+/FOXP3+- expressing cells, however, were very effective in inhibitingthe effector functions of Ag-experienced cells. In our most recent studies, we have observed that TGF-(3m+/FOXP3+ cells have the unique ability to upregulateNotch in target cells resulting in cleavage of Notch to the transcriptional activator form, Notch Intracellular Domain (NICD), which in turn induced HES1, known to be a transcriptional represser. Collectively, these studies lead us to hypothesize that a) membrane-bound TGF-JJ plays an important role inAg- induced tolerance induction in the respiratory tract and b) Co-operation between membrane-bound TGF-JJ- and Notch/NICD-induced pathways is critical for induction of the tolerant state. To test this hypothesis we will:
Aim I. Determine the role of membrane-bound TGF-f) and Notch as Common mediators utilized for tolerance induction in the respiratory tract. Studies will involveanalysis of CD4 T cells from lung-draininglymph nodes (LNs) of mice subjected to two different models of tolerance and use of CD4-specific Notch knockout mice.
Aim II. Determine functional distinctions between soluble and membrane-bound TGF-|J and the importance of Notch cleavage by membrane-bound TGF-P as a critical step in tolerance induction. Molecular interactions between signaling molecules activated downstream of the TGF-P receptor and Notch pathways in target cells will be investigated by biochemical, molecular and imaging techniques.
Aim III. Characterize the effects of a TGF-jJ-rich microenvironment on lung LN dendritic cells and their effects, in turn, on T cells and determine whether HES1 overexpression in a T cell-inducible fashion in mice results in inhibition of allergic airways disease. Expression of the Notch 1 ligand Jagged-1 will be studied on lung LN dendritic cells and the effect of these DCs on CD4 CD25"""""""" and CD4 CD25 cells will be studied. Studies will also involve TGF- P effects on lung and bone marrow-derived DCs. T cell-specific inducible HES1 transgenic mice will be generated to determine whether HES1 overexpression inhibits the development of allergic airways disease. Thus, using a variety of molecular, biochemical and immunological methods and genetically altered mice, our studies will focus on the co-operation between the TGF-B and Notch pathways in tolerance induction in the respiratory tract.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI048927-11
Application #
7744006
Study Section
Lung Cellular, Molecular, and Immunobiology Study Section (LCMI)
Program Officer
Minnicozzi, Michael
Project Start
2001-01-01
Project End
2011-03-14
Budget Start
2010-01-01
Budget End
2011-03-14
Support Year
11
Fiscal Year
2010
Total Cost
$425,208
Indirect Cost
Name
University of Pittsburgh
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
004514360
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Das, Sudipta; Raundhal, Mahesh; Chen, Jie et al. (2017) Respiratory syncytial virus infection of newborn CX3CR1-deficent mice induces a pathogenic pulmonary innate immune response. JCI Insight 2:
Chakraborty, Krishnendu; Raundhal, Mahesh; Chen, Bill B et al. (2017) The mito-DAMP cardiolipin blocks IL-10 production causing persistent inflammation during bacterial pneumonia. Nat Commun 8:13944
Gauthier, Marc; Chakraborty, Krishnendu; Oriss, Timothy B et al. (2017) Severe asthma in humans and mouse model suggests a CXCL10 signature underlies corticosteroid-resistant Th1 bias. JCI Insight 2:
Oriss, Timothy B; Raundhal, Mahesh; Morse, Christina et al. (2017) IRF5 distinguishes severe asthma in humans and drives Th1 phenotype and airway hyperreactivity in mice. JCI Insight 2:
Ray, Anuradha; Raundhal, Mahesh; Oriss, Timothy B et al. (2016) Current concepts of severe asthma. J Clin Invest 126:2394-403
Khare, Anupriya; Raundhal, Mahesh; Chakraborty, Krishnendu et al. (2016) Mitochondrial H2O2 in Lung Antigen-Presenting Cells Blocks NF-?B Activation to Prevent Unwarranted Immune Activation. Cell Rep 15:1700-14
Oczypok, Elizabeth A; Milutinovic, Pavle S; Alcorn, John F et al. (2015) Pulmonary receptor for advanced glycation end-products promotes asthma pathogenesis through IL-33 and accumulation of group 2 innate lymphoid cells. J Allergy Clin Immunol 136:747-756.e4
Raundhal, Mahesh; Morse, Christina; Khare, Anupriya et al. (2015) High IFN-? and low SLPI mark severe asthma in mice and humans. J Clin Invest 125:3037-50
Gauthier, Marc; Ray, Anuradha; Wenzel, Sally E (2015) Evolving Concepts of Asthma. Am J Respir Crit Care Med 192:660-8
Khare, Anupriya; Chakraborty, Krishnendu; Raundhal, Mahesh et al. (2015) Cutting Edge: Dual Function of PPAR? in CD11c+ Cells Ensures Immune Tolerance in the Airways. J Immunol 195:431-5

Showing the most recent 10 out of 36 publications